Table: Takara Bio -Q1 group results
Jul 27 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2016 Jun 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 6.31 5.76 31.00
(+9.5 pct) (+20.5 pct) (+4.3 pct)
Operating 643 mln 111 mln 2.70
(+476.3 pct) (+70.8 pct) (+1.2 pct)
Recurring 653 mln 217 mln 3.05
(+200.2 pct) (+112.7 pct) (-7.6 pct)
Net 285 mln loss 36 mln 1.30
(-2.6 pct)
EPS 2.37 yen loss 0.30 yen 10.80 yen
Ann Div 1.80 yen 1.80 yen
-Q2 div NIL NIL
-Q4 div 1.80 yen 1.80 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T
((Tokyo Headline News Desk +813 6441 1812))